Concord Biotech makes equity investment of $1,500 in Stellon Biotech Inc

02 Jul 2025 Evaluate

Concord Biotech has made an equity investment of $1,500 in Stellon Biotech Inc, USA. This investment represents the subscription of 15 million equity shares at a price of $0.0001 per share resulting into 75% ownership in Stellon Biotech Inc. 

This investment has been made with the objective to expand business operations in USA for the company, through its own subsidiary with a local partner in the United States of America (USA). The company proposed to utilize this U.S. subsidiary to distribute and sell its products in USA.

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Concord Biotech Share Price

1015.90 1.85 (0.18%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×